
Sign up to save your podcasts
Or
FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA News in HTN
II Invasive PE Therapy
III Heart Disease Trends
IV Diabetes Coverage
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
4.9
830830 ratings
FDA approves triple-drug polypill, a change of opinion, a deep dive into invasive pulmonary embolism therapies, heart disease trends, and diabetes care is on fire are the topics John Mandrola, MD, discusses in this week's podcast.
This podcast is intended for healthcare professionals only.
To read a partial transcript or to comment, visit:
https://www.medscape.com/twic
I FDA News in HTN
II Invasive PE Therapy
III Heart Disease Trends
IV Diabetes Coverage
You may also like:
The Bob Harrington Show with the Stephen and Suzanne Weiss Dean of Weill Cornell Medicine, Robert A. Harrington, MD. https://www.medscape.com/author/bob-harrington
Questions or feedback, please contact [email protected]
129 Listeners
13 Listeners
325 Listeners
161 Listeners
493 Listeners
20 Listeners
279 Listeners
3,332 Listeners
87 Listeners
137 Listeners
1,090 Listeners
185 Listeners
515 Listeners
349 Listeners
61 Listeners
24 Listeners
8 Listeners
248 Listeners
426 Listeners
366 Listeners